DC Advisory advises Eurazeo on the sale of Peters Surgical to Advanced Medical Solutions Group plc

Background

  • Founded in 1926, Peters Surgical is a France-based global manufacturer and distributor of high-quality surgical closure devices including sutures, haemostatic clips, haemostatic clamps and internal glues. The portfolio is focused on surgical specialties in the cardiovascular, visceral, and digestive urology and gynaecological surgical indication areas
  • Peters Surgical operates a fully integrated business model, including research and product development, regulatory and clinical affairs, device manufacture, distribution, commercial and after-sales service. It owns manufacturing facilities in France, Thailand, India and Germany and employs approximately 650 people worldwide
  • Eurazeo, a leading global investment group, as a majority shareholder since 2013, has enabled Peters Surgical to expand its presence in the operating room by developing organically and by acquiring new product ranges, such as haemostatic clips or surgical glue. Following numerous acquisitions, Peters Surgical has also increased its shares of direct-selling capabilities, and expanded its geographical presence in the US, Asia and key European countries (including Germany, Poland, among others)
  • In 2023, total revenues stood at €84M from sales in over 90 countries

Process

  • DC Advisory acted as a financial advisor to Eurazeo Small-Mid Buyout and the management team of Peters Surgical
  • DC Advisory conducted a competitive process focused on trade buyers, pre-qualified for their interest in Peters Surgical

Outcome

  • On March 13, 2024, Eurazeo announced the signing of an agreement to sell all the share capital of Peters Surgical to Advanced Medical Solutions Group plc, a world-leading specialist in tissue-healing technologies listed on the London Stock Exchange
  • The transaction will allow Peters Surgical to benefit from significant complementarities with Advanced Medical Solutions Group plc in terms of the combined portfolio of surgical products, of sales capabilities, commercial footprint in key territories and distribution networks
  • The transaction remains subject to the approval of French authorities for foreign direct investment control
  • This transaction demonstrates DC Advisory’s global expertise in the Medtech sector
Date
Sectors
  • Healthcare
Deal type
  • M&A Advisory
Deal locations
United States
France
Deal team
Managing Director
UN SDG Activity
  • GOAL 3: Good Health and Well-being

Disclaimer

For more information, please see our transaction disclaimer

For important information regarding testimonials, please see our disclaimer.

Contact form

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

We collect your personal data if you sign up to receive news or get in touch with us. This is collected by third-party firms on our behalf. We have three separate lists:

  1. DealCloud - which we use as our CRM. DealCloud privacy statement is available here: https://www.intapp.com/privacy/
  2. SalesForce - which we use as our CRM. SalesForce privacy statement is available here: https://www.salesforce.com/uk/company/privacy/
  3. Spotler - which we use to send email marketing campaigns. Spotler privacy statement is available here: https://spotler.co.uk/privacy-policy/

Application form

Application documents*
(Maximum file size of 10 MB. File types accepted: pdf or doc)
* Compulsory fields

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

Back to top